Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration.

@article{Augustin2006VerteporfinAI,
  title={Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration.},
  author={Albert J. Augustin and Ursula M Schmidt-Erfurth},
  journal={American journal of ophthalmology},
  year={2006},
  volume={141 4},
  pages={638-45}
}
PURPOSE To evaluate the efficacy and safety of photodynamic therapy (PDT) with verteporfin combined with intravitreal triamcinolone (IVTA) in occult choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD). DESIGN Single center, nonrandomized interventional case series. METHODS A prospective, noncomparative, interventional case series of 41 eyes of 41 patients with a two-year follow-up period. Verteporfin PDT was performed using the recommended standard… CONTINUE READING